A detailed history of Mint Tower Capital Management B.V. transactions in Catalent, Inc. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 40,000 shares of CTLT stock, worth $2.41 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
40,000
Holding current value
$2.41 Million
% of portfolio
0.72%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $2.14 Million - $2.28 Million
40,000 New
40,000 $2.25 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.